HKDC1 and hepatocellular carcinoma: Similarly, Khan et al. demonstrated that silencing HKDC1 drives metabolic reprogramming from the TCA cycle to mitochondrial pathways, inhibiting hepatocellular carcinoma (HCC) development (18).